Logo for UroGen Pharma Ltd

UroGen Pharma Investor Relations Material

Latest events

Logo for UroGen Pharma Ltd

Q2 2024

UroGen Pharma
Logo for UroGen Pharma

Q2 2024

13 Aug, 2024
Logo for UroGen Pharma

Study Update

13 Jun, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies

Latest reports from UroGen Pharma Ltd

Access all reports
UroGen Pharma Ltd. is a biotechnology company focused on developing and commercializing innovative treatments for urothelial and specialty cancers. The company utilizes its proprietary RTGel technology, a reverse-thermal hydrogel that enhances the therapeutic profiles of existing drugs by providing longer exposure to the urinary tract tissue, making local therapy more effective. The company is headquartered in Princeton, NJ, with operations in Israel, and its shares are listed on the Nasdaq.